Redefining Smoldering Myeloma

Multiple Myeloma Guidelines adopted from NCCN and ESMO

Multiple Myeloma: A retrospective Analysis of the Patients Treated at Ain Shams University Clinical Oncology Department with a Review of the Literature

Early Onset Multiple Myeloma with an Unusual Presentation of Inflammatory Arthritis: A Case Report

B-Cell Maturation Antigen (CD269) as a Predictor for Response to Treatment in Multiple Myeloma Patients.

Role of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients

Fibroblast Growth Factor23 as a Novel Marker of Renal Impairment in Multiple Myeloma

Impact of CRAB Criteria on The Prognosis of Patients with Multiple Myeloma Compared to Other Prognostic Factors in The Era of Novel Agents

Clinical Significance of Cyclin D1 Expression on Trephine Bone Marrow Biopsies in Plasma Cell Myeloma Patients an Egyptian Study

Study of The Role of Soluble Mannose Receptor (sMR/sCD206) in Multiple Myeloma